Agonists and antagonists for lipopolysaccharide-induced cytokines (Q40825123)

24 September 2017

1 reference

title

Agonists and antagonists for lipopolysaccharide-induced cytokines (English)

1 reference

24 September 2017

0 references

Flad HD

1

1 reference

24 September 2017

Loppnow H

series ordinal

2

1 reference

24 September 2017

Rietschel ET

series ordinal

3

1 reference

24 September 2017

Ulmer AJ

series ordinal

4

1 reference

24 September 2017

1 April 1993

1 reference

24 September 2017

1 reference

24 September 2017

187

1 reference

24 September 2017

303-316

1 reference

24 September 2017

3-5

1 reference

Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin 6 is involved in interleukin 1-induced activities

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin-HP1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Induction of human interleukin 1 by bacterial and synthetic lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Biochemistry of endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Protection of mice against lethal endotoxemia by a lipid A precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Lipid X protects mice against fatal Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Suppressive effect of lipid A partial structures on lipopolysaccharide or lipid A-induced release of interleukin 1 by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with alpha- or beta-configuration at position 1

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Multiple receptors for endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

A 28 kDa protein of normal mouse serum binds lipopolysaccharides of gram-negative and lipoteichoic acids of gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Endotoxin-neutralizing capacity of soluble CD14

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Dysregulation of in vitro cytokine production by monocytes during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980346-3

7 January 2021

10.1016/S0171-2985(11)80346-3

Identifiers

DOI

0 references

1 reference